Latham & Watkins LLP represented the underwriters in the offering.Monte Rosa Therapeutics, Inc. executed its initial public offering of 11,700,000 shares of common stock at a public…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
